-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OlS+N0RvEYPehemvWTaQVsgqioOAvBBu2tp9ddb7IuVdaiM7whYA07EjmMNI/V/2 a8nxOySu7sWaMSqpPOVyvA== 0000897069-09-001524.txt : 20091119 0000897069-09-001524.hdr.sgml : 20091119 20091119130839 ACCESSION NUMBER: 0000897069-09-001524 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091116 FILED AS OF DATE: 20091119 DATE AS OF CHANGE: 20091119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOFMEISTER THOMAS CENTRAL INDEX KEY: 0001307464 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-10670 FILM NUMBER: 091195367 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER, SUITE 1200 CITY: BETHESDA STATE: MD ZIP: 20814 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HANGER ORTHOPEDIC GROUP INC CENTRAL INDEX KEY: 0000722723 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 840904275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019860701 MAIL ADDRESS: STREET 1: TWO BETHESDA METRO CENTER STREET 2: SUITE 1300 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: SEQUEL CORP DATE OF NAME CHANGE: 19890814 FORMER COMPANY: FORMER CONFORMED NAME: CELLTECH COMMUNICATIONS INC DATE OF NAME CHANGE: 19860304 4/A 1 form4a_thomashofmeisterex.xml X0303 4/A 2009-11-16 2009-11-18 0 0000722723 HANGER ORTHOPEDIC GROUP INC HGR 0001307464 HOFMEISTER THOMAS TWO BETHESDA METRO CENTER, SUITE 1200 BETHESDA MD 20814 0 1 0 0 VP of Finance & CAO Common Stock 2009-11-16 4 S 0 660 13.499 D 21238 D The shares of common stock were sold to cover taxes incurred as a result of the vesting of restricted shares. These shares were sold at a range of sale prices from $13.4834 to $13.51. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Includes (i) unvested restricted shares and fully vested shares which total 5,340 shares of stock from an initial grant of 6,000 shares of restricted stock made on November 13, 2008; (ii) unvested restricted shares and fully vested shares which total 11,548 shares of stock from an initial grant of 15,000 shares of restricted stock made on August 9, 2007; (iii) unvested restricted shares and fully vested shares which total 3,650 shares of stock from an initial grant of 10,000 shares of restricted stock made on June 12, 2006; and (iv) 700 shares of common stock which were derived from a previous grant of restricted shares which are now fully vested. All remaining unvested restricted shares will continue to vest at a rate of 25% per year of the original grant amount on the anniversary date of the grant. This Amended Form 4 is filed solely for the purpose of correcting an inadvertent typographical error with respect to footnote 3 to the Form 4 filed for the reporting person on November 18, 2009. The footnote 3 to this Amended Form 4 replaces the footnote 3 in the original Form 4 filed on November 18, 2009 in its entirety. /s/ Teri L. Champ 2009-11-19 -----END PRIVACY-ENHANCED MESSAGE-----